Strikingly, Pan et al. showed that interruption of the glycolysis/H4K12 lactylation/PKM2 loop by pharmacological or genetic approaches inhibited microglial activation, reduced Aβ pathology, and improved cognitive function of AD mice. This evidence concerns the gene PKM and Alzheimer disease.